SE0014855029
© PR Newswire
10.12.2025
IMP A-SDB
LISTED
STO
Implantica strengthens market expansion as Italy's leading Careggi University Hospital in Florence introduces RefluxStop®
News Preview
VADUZ, Liechtenstein, Dec. 10, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop® for the treatment of acid reflux (GERD), a treatment field with 1 billion sufferers, announces adoption of RefluxStop at the world-renowned Careggi U...
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
IMP A-SDB
LISTED
STO
Implantica publishes Interim Report January - September 2025 (Q3)
News Preview
VADUZ, Liechtenstein, Oct. 31, 2025 /PRNewswire/ --
RefluxStop® Nears FDA Approval - Strong Momentum Toward US Market Entry
Significant events in the third quarter of 2025
Rec...
Themefolio
Profiler
Peergroup
© PR Newswire
17.09.2025
IMP A-SDB
LISTED
STO
Implantica's RefluxStop® sparks strong excitement at the American Foregut Society meeting, ahead of pending US FDA approval
News Preview
VADUZ, Liechtenstein, Sept. 17, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment field with over 1 billion sufferers, announces RefluxStop® was met with great enthusiasm and posi...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
14.08.2025
IMP A-SDB
LISTED
STO
Implantica publishes Interim Report January - June 2025 (Q2)
News Preview
VADUZ, Liechtenstein, Aug. 14, 2025 /PRNewswire/ --
Transforming Clinical Excellence of RefluxStop® into Strategic Market Momentum
Significant events in the second quarter of 2025
FDA PMA Submission Completed - Submitted third and final module of the U.S. FDA pre-market approval (PMA) application for RefluxStop®, including responses to question...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
13.08.2025
IMP A-SDB
LISTED
STO
Implantica finishes new multi-cavity production tool for RefluxStop® to support manufacturing ramp-up in the U.S. pending FDA approval
News Preview
VADUZ, Liechtenstein, Aug. 13, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment field with over 1 billion sufferers, announces completion and initial validation of a new RefluxSt...
Themefolio
Profiler
Peergroup
© PR Newswire
07.08.2025
IMP A-SDB
LISTED
STO
Implantica announces second publication of groundbreaking 5-year results from the landmark RefluxStop® clinical study
News Preview
VADUZ, Liechtenstein, Aug. 7, 2025 /PRNewswire/ -- Implantica AG (publ), a leading medtech company pioneering advanced implantable medical technologies, today announced the second peer-reviewed publication of the remarkable 5-year outcomes from its CE mark clinical study of RefluxStop®, a revolutionary device for the treatment of acid reflux-a co...
Themefolio
Profiler
Peergroup
© PR Newswire
01.07.2025
IMP A-SDB
LISTED
STO
Implantica announces publication of the landmark RefluxStop® 5-year clinical study results demonstrating excellent long-term success
News Preview
VADUZ, Liechtenstein, July 1, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of treatment for acid reflux with its unique device RefluxStop®, a treatment field with 1 billion sufferers, announces the publication of RefluxStop's extraordinary 5-year clinical data for food passageway-related outcomes in the prestigio...
Themefolio
Profiler
Peergroup
© PR Newswire
24.06.2025
IMP A-SDB
LISTED
STO
Implantica submits the last and final module 3 of the FDA PMA Application for RefluxStop® for US market approval
News Preview
VADUZ, Liechtenstein, June 24, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop® for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces the submission of the third and final module of the RefluxSt...
Themefolio
Profiler
Peergroup
© PR Newswire
17.06.2025
IMP A-SDB
LISTED
STO
Implantica announces successful UK RefluxStop™ Users Meeting addressing growing demand after the final and positive UK NICE recommendations on use of RefluxStop in NHS public hospitals
News Preview
VADUZ, Liechtenstein, June 17, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of treatment for acid reflux with its unique device RefluxStop™, a treatment field with 1 billion sufferers, announces the successful first UK National Users Meeting bringing together 21 top anti-reflux experts in UK last week. Surgeons e...
Themefolio
Profiler
Peergroup
© PR Newswire
12.06.2025
IMP A-SDB
LISTED
STO
Implantica announces new real-world Swiss study on 99 RefluxStop™ patients comparing small and large hiatal hernia, confirming equally excellent long-term results
News Preview
VADUZ, Liechtenstein, June 12, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces the publication of a new independent real-world study from S...
Themefolio
Profiler
Peergroup
© PR Newswire
04.06.2025
IMP A-SDB
LISTED
STO
Implantica announces that UK NICE has published positive recommendations for the RefluxStop™ procedure in the NHS public hospitals
News Preview
VADUZ, Liechtenstein, June 4, 2025 /PRNewswire/ -- Implantica AG (publ.), providing the unique device RefluxStop™ for the treatment of acid reflux, announces that the world-renowned National Institute for Healthcare Excellence (NICE) payer advisory agency for NHS public hospitals in the UK has published positive Interventional Procedures Guidance...
Themefolio
Profiler
Peergroup
© PR Newswire
27.05.2025
IMP A-SDB
LISTED
STO
Implantica's RefluxStop™ stimulates intensive dialogue at DDW, the world's largest Digestive Disease conference, held in the U.S.
News Preview
VADUZ, Liechtenstein, May 27, 2025 /PRNewswire/ -- Implantica AG (publ.) reports successful pre-launch activities in the U.S., pending FDA approval, with European real-world clinical evidence generating much interest from U.S. surgeons.
Several presentations on RefuxStop™ were held at DDW, an impressive hub for discussing the latest innovations...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
15.05.2025
IMP A-SDB
LISTED
STO
Bulletin from the Annual General Meeting of Implantica AG
News Preview
VADUZ, Liechtenstein, May 15, 2025 /PRNewswire/ -- Today, May 15, 2025, the annual general meeting (the "AGM") of Implantica AG (publ) was held in Ruggell, Liechtenstein. The general meeting resolved to adopt all of the board of directors' resolution proposals. A summary of the resolutions adopted at the general meeting is set out below.
The gen...
Themefolio
Profiler
Peergroup
© PR Newswire
09.05.2025
IMP A-SDB
LISTED
STO
Implantica publishes Interim Report January - March 2025 (Q1)
News Preview
VADUZ, Liechtenstein, May 9, 2025 /PRNewswire/ --
Global expansion of RefluxStop™
Significant events in the first quarter of 2025
Received positive feedback from U.S. FDA on our Clinical Module 2 Premarket Approval (PMA) application. FDA accepted Module 1 containing the quality systems and manufacturing information for RefluxStop™, and this modu...
Themefolio
Profiler
Peergroup
© PR Newswire
02.05.2025
IMP A-SDB
LISTED
STO
Implantica presents the first quarter 2025 on May 9 at 15:00 CEST
News Preview
VADUZ, Liechtenstein, May 2, 2025 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the first quarter 2025 at 15:00 CEST on May 9. The interim report for the first quarter will be published at 8:00 a.m. CEST on the same day.
The presentation will be in English via an audiocast with teleconference:
If you wish to partic...
Themefolio
Profiler
Peergroup
© PR Newswire
25.04.2025
IMP A-SDB
LISTED
STO
Notice of Annual General Meeting of Implantica AG
News Preview
VADUZ, Liechtenstein, April 25, 2025 /PRNewswire/ -- The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited to attend the annual general meeting to be held on Thursday, May 15, 2025, at 14:00 at Hotel Kommod, Industriering 14, 9491 Ruggell, Liechtenstein.
Right to participate and notice
Anyone wishing to...
Themefolio
Profiler
Peergroup
© PR Newswire
23.04.2025
IMP A-SDB
LISTED
STO
Implantica opens a new RefluxStop™ center in a new region of Spain, addressing the fast-growing demand
News Preview
VADUZ, Liechtenstein, April 23, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces another Center of Excellence in Spain to offer RefluxStop™,...
Themefolio
Profiler
Peergroup
© PR Newswire
15.04.2025
IMP A-SDB
LISTED
STO
Implantica publishes Annual Report 2024
News Preview
VADUZ, Liechtenstein, April 15, 2025 /PRNewswire/ -- Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2024. The annual report is now available on the company's website.
"Today, we are proud to report that RefluxStop™ has achieved a crucial...
Themefolio
Profiler
Peergroup
© PR Newswire
10.04.2025
IMP A-SDB
LISTED
STO
Implantica announces a newly published real-world study from Germany reinforcing the excellent RefluxStop™ results
News Preview
VADUZ, Liechtenstein, April 10, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces a new article from Germany in the well-respected Journal of...
Themefolio
Profiler
Peergroup
© PR Newswire
19.03.2025
IMP A-SDB
LISTED
STO
Implantica announces further expansion of RefluxStop™ centers of excellence and patient access in Spain
News Preview
VADUZ, Liechtenstein, March 19, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces that the RefluxStop™ procedure is now being performed at th...
Themefolio
Profiler
Peergroup
© PR Newswire
14.02.2025
IMP A-SDB
LISTED
STO
Implantica publishes Year-end Report, January - December 2024 (Q4)
News Preview
VADUZ, Liechtenstein, Feb. 14, 2025 /PRNewswire/ --
RefluxStop™ FDA Milestone
Significant events in the fourth quarter
Submitted extensive clinical Module 2 of the 3 module-process in the Premarket Approval (PMA) application to U.S. FDA. Most crucial module containing clinical portion including 5-year long-term follow-up of CE mark pivotal stud...
Themefolio
Profiler
Peergroup
© PR Newswire
13.02.2025
IMP A-SDB
LISTED
STO
Implantica announces positive feedback received from U.S. FDA of the RefluxStop™ PMA Module 2 submission
News Preview
VADUZ, Liechtenstein, Feb. 13, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces that U.S. FDA has completed its review of the PMA Module 2 sub...
Themefolio
Profiler
Peergroup
© PR Newswire
12.02.2025
IMP A-SDB
LISTED
STO
Implantica announces Module 1 is accepted and closed by FDA in the PMA application for RefluxStop™
News Preview
VADUZ, Liechtenstein, Feb. 12, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, is pleased to announce that the FDA has accepted Module 1 of the company...
Themefolio
Profiler
Peergroup
© PR Newswire
06.02.2025
IMP A-SDB
LISTED
STO
Implantica announces onboarding of the world-leading La Paz University Hospital, Spain
News Preview
VADUZ, Liechtenstein, Feb. 6, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces onboarding of the 12th Center of Excellence in Spain, the La...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2025
IMP A-SDB
LISTED
STO
Implantica announces completion of first GI-focused RefluxStop™ educational meeting by a prestigious NHS Hospital in the UK
News Preview
VADUZ, Liechtenstein, Feb. 4, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, reports that a leading pioneer of innovation healthcare services in the...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2025
IMP A-SDB
LISTED
STO
Implantica announces new exceptional published data from the largest real-world study from Germany
News Preview
VADUZ, Liechtenstein, Jan. 9, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces the journal Surgery Open Science, affiliated with the prestig...
Themefolio
Profiler
Peergroup
© PR Newswire
23.12.2024
IMP A-SDB
LISTED
STO
Implantica to be included in Nasdaq's First North 25 index
News Preview
VADUZ, Liechtenstein, Dec. 23, 2024 /PRNewswire/ -- Implantica AG (publ), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces it will join the Nasdaq First North 25 index effective Januar...
Themefolio
Profiler
Peergroup
© PR Newswire
18.12.2024
IMP A-SDB
LISTED
STO
Implantica announces two new RefluxStop™ University Hospitals in Spain, leading to 10 active centers and many more to join soon
News Preview
VADUZ, Liechtenstein, Dec. 18, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces the completion of the onboarding of two new University Hospi...
Themefolio
Profiler
Peergroup
© PR Newswire
17.12.2024
IMP A-SDB
LISTED
STO
Implantica deepens market penetration in Italy with the addition of the ninth RefluxStop™ Center of Excellence and several lined up to start near-term
News Preview
VADUZ, Liechtenstein, Dec. 17, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces the first RefluxStop™ procedures were completed this month b...
Themefolio
Profiler
Peergroup
© PR Newswire
15.11.2024
IMP A-SDB
LISTED
STO
Implantica publishes Interim Report January - September 2024 (Q3)
News Preview
VADUZ, Liechtenstein, Nov. 15, 2024 /PRNewswire/ -- RefluxStop™ achieves crucial FDA milestone and leaps forward with strong momentum in both the US and Europe
Significant events in the third quarter of 2024
First national RefluxStop™ user meetings took place in Italy and Spain with over 40 leading surgeons attending - just 1.5 years after marke...
Themefolio
Profiler
Peergroup
© PR Newswire
14.11.2024
IMP A-SDB
LISTED
STO
Implantica submits FDA PMA application Clinical Module 2 for RefluxStop™ for U.S. market approval
News Preview
VADUZ, Liechtenstein, Nov. 14, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces the submission of the second clinical module of the Premarke...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2024
IMP A-SDB
LISTED
STO
Implantica announces highly successful 2024 American Foregut Society meeting where RefluxStop® received remarkable pre-launch market feedback
News Preview
VADUZ, Liechtenstein, Oct. 10, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, is pleased to report an impressive level of support from a large number of U.S. doctors who are interested to start with RefluxStop®* after launch, pending FDA approval, driven by the very...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2024
IMP A-SDB
LISTED
STO
Implantica welcomes 23 top anti-reflux surgeons from 17 leading centers in the first User meeting in Spain, 1.5 years post country launch
News Preview
VADUZ, Liechtenstein, Oct. 1, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces that the first Spanish User meeting took place over two days in Alcalá de Henares, with surgeons gathering for peer-to-peer learning, training and to exchange experience on the st...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2024
IMP A-SDB
LISTED
STO
Implantica shares a landmark review article on standard of care Nissen Fundoplication anti-reflux surgery - in light of the recently announced excellent RefluxStop™ 5-year results
News Preview
VADUZ, Liechtenstein, Sept. 25, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, reports on the results of the recently published landmark study in the...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2024
IMP A-SDB
LISTED
STO
Implantica announces finalization of remarkable 5-year pivotal CE mark study results and gears up for the Module 2 submission of PMA application to FDA for RefluxStop™
News Preview
VADUZ, Liechtenstein, Sept. 25, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces finalization of the 5-year CE mark study results as part of t...
Themefolio
Profiler
Peergroup
© PR Newswire
19.09.2024
IMP A-SDB
LISTED
STO
Implantica conducts first national RefluxStop™ User meeting with 21 participating surgeons, 1.5 years after launch in Italy
News Preview
VADUZ, Liechtenstein, Sept. 19, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, had the pleasure to host a regional full day User meeting with 21 surgeons attending last week in Milan to exchange experience and train on the standardized surgical technique, just 1.5 y...
Themefolio
Profiler
Peergroup
© PR Newswire
18.09.2024
IMP A-SDB
LISTED
STO
Implantica announces excellent data from an independent study of 158 RefluxStop™ patients from two centers in Germany - presented at the AUGIS meeting in UK
News Preview
VADUZ, Liechtenstein, Sept. 18, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, reports that the study "Pooled two-year results of the novel RefluxStop implantable device in management of gastroesophageal reflux disease in Germany: Retrospective analysis," shows over...
Themefolio
Profiler
Peergroup
© PR Newswire
21.08.2024
IMP A-SDB
LISTED
STO
Implantica publishes Interim Report January - June 2024 (Q2)
News Preview
VADUZ, Liechtenstein, Aug. 21, 2024 /PRNewswire/ -- RefluxStop™ is on a wave of success - carried by a multitude of published studies with excellent outcomes from leading European Reflux-centers
Significant events in the second quarter of 2024
Module 1 review of Premarket Approval (PMA) application for RefluxStop™ completed by US FDAFindings pre...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2024
IMP A-SDB
LISTED
STO
Implantica announces RefluxStop™ pivotal 4-year study results published in the prestigious journal Surgical Endoscopy
News Preview
VADUZ, Liechtenstein, Aug. 20, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces excellent long-term safety and clinical 4-year outcomes with the RefluxStop device (in the prospective multi-center CE study), which have recently been published in the prestigio...
Themefolio
Profiler
Peergroup
© PR Newswire
15.08.2024
IMP A-SDB
LISTED
STO
Implantica announces another landmark real-world RefluxStop™ study demonstrating excellent outcomes published in a prestigious top-tier journal
News Preview
VADUZ, Liechtenstein, Aug. 15, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces another key milestone with an independent study demonstrating robust safety and significant improvement in GERD symptoms after the RefluxStop™ procedure published in Swiss Medica...
Themefolio
Profiler
Peergroup
© PR Newswire
14.08.2024
IMP A-SDB
LISTED
STO
Implantica presents the second quarter 2024 on August 21 at 15:00 CEST
News Preview
VADUZ, Liechtenstein, Aug. 14, 2024 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the second quarter 2024 at 15:00 CEST on August 21. The interim report for the second quarter will be published at 8:00 a.m. CEST on the same day.
The presentation will be in English via an audiocast with teleconference:
If you wish t...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
